NCT00820547 Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients Status COMPLETED Phase PHASE2
NCT00818961 Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer Status TERMINATED Phase PHASE2
NCT00816595 Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status COMPLETED Phase PHASE2
NCT00813150 Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple Myeloma Status COMPLETED Phase PHASE3
NCT00809341 R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma Status TERMINATED Phase PHASE2
NCT00808899 Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma Status TERMINATED Phase PHASE2
NCT00807196 Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma Status UNKNOWN Phase PHASE1/PHASE2
NCT00801931 Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders Status TERMINATED Phase PHASE1/PHASE2
NCT00801632 Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection Status COMPLETED Phase PHASE2
NCT00801411 Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery Status UNKNOWN Phase PHASE2
NCT00801281 First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance. Status COMPLETED Phase PHASE3
NCT00800839 Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide Status COMPLETED Phase PHASE2
NCT00796562 Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy Status COMPLETED Phase PHASE2
NCT00794820 Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline Status COMPLETED Phase PHASE2
NCT00793845 Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma Status COMPLETED Phase PHASE2
NCT00792948 Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00791037 Vaccine Therapy in Treating Patients With Stage IV Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00789776 Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer Status COMPLETED Phase PHASE1/PHASE2